GLP-1 receptor agonists × body weight & composition

TrialDiabetologia2020

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial.

Rory J McCrimmon et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 178 people · 2020

Range includes no effect

No clear effect on body weight & composition

−0.79−2.10 to +0.51

As reported

difference −0.79, 95% CI −2.10 to 0.51

One number in the abstract

the abstract, start to end

(estimated treatment difference: -0.79 [95% CI -2.10, 0.51]).

← favours treatmentfavours comparator →
could be chance
Body weight & composition
−0.79−2.10 to 0.51
SGLT2 inhibitorsGLP-1 receptor agonistsBody weight & composition
1 / 3

94 papers cite itlatest 60 shown

2020
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31897524